Breakthrough Therapies

A significant nonprofit experiment is underway, aiming for FDA approval of MDMA-assisted psychotherapy for PTSD by 2022. With the FDA recognizing both MDMA and psilocybin as breakthrough therapies, the future looks promising for these treatments. As these therapies require trained professionals for administration, a network of psychedelic clinics is anticipated to emerge, paving the way for a new era in mental health treatment.